Qiao Li

3.2k citations
152 papers · 2.1k indexed · 1 hit paper · h-index 25
Topics
Cancer Treatment and Pharmacology (33 papers)HER2/EGFR in Cancer Research (32 papers)Advanced Breast Cancer Therapies (27 papers)
Journals
Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Qiao Li

138 papers receiving 2.1k citations

Hit Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combin...202420262025202410203040

Peers

Qiao Li
Comparison fields: 5 of 107
  • Oncology 966
  • Cancer Research 778
  • Molecular Biology 667
  • Pulmonary and Respiratory Medicine 542
  • Radiology, Nuclear Medicine and Imaging 286
Replace Shuang Liu with:
Shuang Liu China
Wei-Shone Chen Taiwan
Ling Xu China
Romualdo Barroso‐Sousa Brazil
Shotaro Naito Japan
Hiromitsu Mimata Japan
Zhongyu Yuan China
Shan Wang China
Tonya C. Walser United States
Qiao Li relative to Shuang Liu China Shuang Liu's profile →
Citations per field
00.5×1.5×2.0×
Shuang Liu · 1×
Citations per year

Countries citing papers authored by Qiao Li

Since Specialization
Citations

This map shows the geographic impact of Qiao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiao Li more than expected).

Fields of papers citing papers by Qiao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiao Li. The network helps show where Qiao Li may publish in the future.

Co-authorship network of co-authors of Qiao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qiao Li. A scholar is included among the top collaborators of Qiao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiao Li. Qiao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 0
5 0
6 3
7 0
8 2
9 2
10 3
11 4
12 11
13 18
14 29
15 9
16 61
17 27
18 5
19 16
20 1

About Qiao Li

Qiao Li is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 152 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (33 papers), HER2/EGFR in Cancer Research (32 papers) and Advanced Breast Cancer Therapies (27 papers). The work is most often cited by research in Cancer Research (778 citations), Oncology (966 citations) and Pulmonary and Respiratory Medicine (542 citations). Qiao Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fei Ma, Binghe Xu, Shanshan Chen, Pin Zhang, Ruigang Cai, Yang Luo, Ying Fan, Jiayu Wang, Peng Yuan and Xiuwen Guan. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026